James Myatt

Title: Innovations of James Myatt in Pharmaceutical Chemistry

Introduction

James Myatt is a notable inventor based in Harlow, GB. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that target specific receptors in the body. With a total of 2 patents to his name, Myatt's work is recognized for its potential therapeutic applications.

Latest Patents

Myatt's latest patents include innovative compounds such as oxadiazole substituted indazole derivatives for use as sphingosine 1-phosphate (S1P) agonists. This invention provides compounds of formula (I) or salts thereof, which exhibit pharmacological activity. The patent details processes for their preparation, pharmaceutical compositions containing them, and their use in treating various disorders mediated by S1P1 receptors. Another significant patent involves indole derivatives as S1P1 receptor modulators, focusing on compounds of formula (I) and their pharmaceutical applications in treating conditions mediated via the S1P1 receptor.

Career Highlights

James Myatt is currently associated with Glaxo Group Limited, where he continues to advance his research and development efforts. His work has been instrumental in creating new therapeutic options for patients suffering from various disorders.

Collaborations

Throughout his career, Myatt has collaborated with esteemed colleagues, including Mahmood Ahmed and David Norton. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.

Conclusion

James Myatt's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as a key innovator in the field. His work continues to pave the way for new treatments that can significantly impact patient care.